Polycystic Ovary Syndrome renamed to Polyendocrine Metabolic Ovarian Syndrome. 14-year global consensus process led to renaming. Old name focused on 'cysts' instead of 'arrested follicles', causing missed diagnoses. Professor Helena Teede led effort with 56 organizations and 22,000 participants. Lorna Berry, Australian PMOS advocate, called renaming 'accountability and progress'. Condition affects 1 in 8 women but remains undiagnosed. New name to be integrated into clinical practice over three years